Chlodantane

Overview

Chlodantane (ADK-910) is a non-peptide aryl-substituted 2-aminoadamantane amide, structurally related to bromantane and classified in Soviet pharmacological literature as an actoprotector/adaptogen. It has never been approved for human use in any jurisdiction and remains entirely unevaluated in clinical trials. All available data derive from animal and cell-culture experiments conducted in the former Soviet Union.

Mechanism of Action

The only mechanistic hypothesis in the literature is a proposed membrane-protective action: chlodantane is suggested to increase cell-membrane stability by decreasing lipid peroxidation (LPO), as described in a 2012 review citing a 2001 Russian primary source that was not independently retrieved. No receptor-binding, enzyme-inhibition, or target-engagement data have been published.

Research Summary

No human data exist; a 2012 review explicitly states that all pharmacological data derive from animal or cell-culture experiments, with no clinical research conducted. In unspecified animal models, chlodantane enhanced resistance to physical and toxic-chemical stressors, produced immunostimulating effects in stress-induced immunodeficiency, and protected against hypoxia, high and low ambient temperature, and toxic chemical challenge. Effects were reported to appear after a single administration, and immunostimulant activity was described as more pronounced than that of bromantane.

Reported Side Effects

• No human safety data available
• No acute or chronic animal toxicity endpoints (LD₅₀, NOAEL) retrievable
• Never evaluated in clinical trials
• Gray-market products lack quality control or purity verification

Compare Chlodantane with Others

Research References

• [Adamantane derivatives enhancing body's resistance to emergencies]. 1999. PMID 10222828.
• The Pharmacology of Actoprotectors: Practical Application for Improvement of Mental and Physical Performance. 2012.
• PubChem Compound Summary for CID 959689, Chlodantane.

Frequently asked questions

Has Chlodantane been independently lab-tested?

Disclosed Labs has collected 1 Certificate of Analysis (COA) for Chlodantane from 1 independent testing lab. 1 vendor has submitted material for testing. Products average 99.9% tested purity across the corpus. Full testing data is available at https://www.disclosedlabs.com/peptides/chlodantane/testing.

How does Chlodantane work?

The only mechanistic hypothesis in the literature is a proposed membrane-protective action: chlodantane is suggested to increase cell-membrane stability by decreasing lipid peroxidation (LPO), as described in a 2012 review citing a 2001 Russian primary source that was not independently retrieved. No receptor-binding, enzyme-inhibition, or target-engagement data have been published.

What does the research say about Chlodantane?

No human data exist; a 2012 review explicitly states that all pharmacological data derive from animal or cell-culture experiments, with no clinical research conducted. In unspecified animal models, chlodantane enhanced resistance to physical and toxic-chemical stressors, produced immunostimulating effects in stress-induced immunodeficiency, and protected against hypoxia, high and low ambient temperature, and toxic chemical challenge. Effects were reported to appear after a single administration, and immunostimulant activity was described as more pronounced than that of bromantane.